Drug profile · INN
tetracosactide
SYNACTHEN DEPOT 1 MG/1 ML
tetracosactide (SYNACTHEN DEPOT 1 MG/1 ML) is a melanocortin receptor 2 agonist.
TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — tetracosactide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.78
Quick answer
tetracosactide (SYNACTHEN DEPOT 1 MG/1 ML) is a melanocortin receptor 2 agonist.
Key facts
INN tetracosactide
Brand SYNACTHEN DEPOT 1 MG/1 ML
Mechanism Melanocortin receptor 2 agonist
Target Adrenocorticotropic hormone receptor
Mechanism of action
Melanocortin receptor 2 agonist
Primary target: Adrenocorticotropic hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tetracosactide?
tetracosactide (SYNACTHEN DEPOT 1 MG/1 ML) is a melanocortin receptor 2 agonist.
What is the brand name for tetracosactide?
SYNACTHEN DEPOT 1 MG/1 ML is a marketed brand name for tetracosactide. Check FDA Drugs@FDA for the current US label holder and prescribing information.